Allogene Therapeutics, Inc.

OPPENHEIMER & CO INC ALLO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/6/2025

Shares

10,500

Value ($000)

13

Weight

0.0%

2019 Q4 - 2025 Q3 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/6/2025	13	0.0%	10,500	9/30/2025
2025 Q2	7/31/2025	12	0.0%	10,500	6/30/2025
2025 Q1	4/23/2025	15	0.0%	10,500	3/31/2025
2024 Q4	2/5/2025	22	0.0%	10,500	12/31/2024
2024 Q3	11/5/2024	29	0.0%	10,500	9/30/2024
2024 Q2	8/8/2024	24	0.0%	10,500	6/30/2024
2024 Q1	5/7/2024	47	0.0%	10,500	3/31/2024
2023 Q4	2/13/2024	40	0.0%	12,400	12/31/2023
2023 Q3	11/8/2023	39	0.0%	12,400	9/30/2023
2023 Q2	8/3/2023	62	0.0%	12,400	6/30/2023
2022 Q3	11/14/2022	123	0.0%	11,350	9/30/2022
2022 Q2	8/8/2022	189	0.0%	16,550	6/30/2022
2022 Q1	5/12/2022	137	0.0%	15,050	3/31/2022
2021 Q4	2/2/2022	180	0.0%	12,050	12/31/2021
2021 Q3	11/12/2021	338	0.0%	13,145	9/30/2021
2021 Q2	8/3/2021	388	0.0%	14,884	6/30/2021
2021 Q1	5/10/2021	883	0.0%	25,023	3/31/2021
2020 Q1	5/8/2020	259	0.0%	13,300	3/31/2020
2019 Q4	2/7/2020	203	0.0%	7,800	12/31/2019